Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Location status: Recruiting
Location contact
Brett Cucchiara, MD
PRINCIPAL_INVESTIGATOR
Stephanie Cummings
CONTACT
NCT Number: NCT06368193
This trial aims to demonstrate that the Neuralert Monitoring System will detect strokes before they would be identified by current standard of care. Each patient will be monitored for up to five days, depending on device connectivity or battery duration. Each monitoring session will consist of wearing a Neuralert device on each arm. For this pilot trial, we are interested in learning about Wi-Fi connectivity, successful data transmission, integration into clinical workflow, usability and tolerability.
Interested in participating?
Request Info22 year and older
All sexes
Interventional
Not applicable
Philadelphia, Pennsylvania, 19104, United States
Location status: Recruiting
Brett Cucchiara, MD
PRINCIPAL_INVESTIGATOR
Stephanie Cummings
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Ø Interventions or procedures that are high-risk for stroke performed during the hospitalization, which may include:
Ø Other cardiac procedures along with a high-risk medical history:
Exclusion criteria
(all must be no)
Device to identify upper extremity asymmetry in patients who are high risk for stroke.
Time frame: Up to 5 days post patient surgery
The time from the nurse receiving an alert to the time they respond after assessing the patient.
Time frame: Up to 5 days post patient surgery
The time to successful generation of an alert to staff when asymmetry or low battery is detected.
Time frame: Up to 5 days post patient surgery
The number of strokes identified by the Neuralert device and the number of strokes identified by usual care. If a stroke is identified at the next clinical evaluation after an alarm occurs, it will be considered to have been detected by the Neuralert device.
Time frame: Up to 5 days post patient surgery
The tolerability and impact on clinical workflow and patient feedback on tolerability after study completion.
Contact information is provided by the study sponsor or research team.
Neuralert Technologies LLC
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07362303
Brain Diseases, Cardiovascular Diseases
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT05778981
Brain Diseases, Cardiac Death
Independencia, Santiago Metropolitan, Chile
View Trial DetailsNCT06921616
Brain Diseases, Cardiovascular Diseases
Luzhou, China
View Trial DetailsNCT06924983
Brain Diseases, Cardiovascular Diseases
Luzhou, China
View Trial Details